We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




New Acquisition Method Expands MS Range and Sampling Depth

By LabMedica International staff writers
Posted on 31 May 2018
A major challenge for proteomics, particularly in studies using complex samples with high dynamic ranges, is that only a small proportion of peptides in a sample are selected for analysis.

This means that high-abundance peptides are overwhelmingly selected for, making identification and quantification of lower-abundance molecules challenging and highly variable across different samples. More...
One approach to tackling this problem is improving MS2-level analysis by developing methods capable of fragmenting and analyzing a higher proportion of the precursor ions introduced into the mass spectrometer (MS).

Scientists at the Max Planck Institute of Biochemistry (Martinsried, Germany) developed an approach, named the BoxCar acquisition method that adjusts the sampling of ions at the MS1 level during MS analysis to expand the instrument's dynamic range and sampling depth. This approach significantly boosts the sensitivity and reproducibility of conventional data-dependent MS acquisition.

In the BoxCar method, the team focused on this MS1 level, and the limitations of the ion storage device (C-trap) used in some of Orbitrap instruments, specifically. In these instruments, ions are generated by electrospray and then passed into the C-trap before moving into the Orbitrap for analysis. However, according to the authors, the C-trap can store only one million charges at a time, which, they noted, is around 1% of the ions generated during its fill time, meaning that around 99% of ions generated are never analyzed. Because high-abundance ions are overrepresented in the overall sample, they will also be overrepresented in the 1% of the ions that are ultimately analyzed, crowding out lower-abundance molecules.

The investigators applied the method to human plasma and found that it provided an additional order of magnitude of dynamic range, a notable boost in performance, given that plasma can exceed ten orders of dynamic range. They also found it helped substantially with the "missing data" problem that has limited the usefulness of shotgun proteomics in work like clinical biomarker research, where reproducible quantification across large numbers of samples is key. In an analysis of 10 HeLa cell digests using 45-minute MS runs, the scientists found the BoxCar method quantified 7,222 proteins per run, 6,216 of which were quantified in all 10 runs. An equivalent study using a conventional shotgun method quantified 5,050 proteins, 4,180 of them in all 10 runs. In one hour analyses, the method provided MS1-level evidence for more than 90% of the proteome of a human cancer cell line that had previously been identified in 24 fractions.

Florian Meier, MSc, the lead author of the study, said, “It's now no longer a big deal to generate a very deep library of a sample by fractionating. If you have a lot of samples, then the time you spend on generating libraries is not a lot compared to the time you can spend on actually quantifying your samples. That's the workflow we have set up for clinical samples in particular.” The study was published on May 7, 2018, in the journal Nature Methods.

Related Links:
Max Planck Institute of Biochemistry


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Electrolyte Analyzer
CBS-4000 (CBS-400)
Immunofluorescence Analyzer
IFA System
Urine Analyzer
respons® UDS100
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: NTM are about 200 environmental bacteria found in soil and water that can cause chronic, tuberculosis-like lung infections but are distinct from the Mycobacterium tuberculosis complex (Image Credit: Adobe Stock)

Rapid CRISPR Test Identifies Nontuberculous Mycobacteria Species from Respiratory Samples

Chronic lung infections caused by nontuberculous mycobacteria (NTM) are increasingly recognized but frequently mistaken for tuberculosis, complicating diagnosis and care. These infections may affect as... Read more

Immunology

view channel
Image: Although many people harbor latent Epstein-Barr virus (EBV), growing evidence has linked the virus to MS pathobiology (Image Credit: Adobe Stock)

Blood EBV Activity Biomarkers May Predict Multiple Sclerosis Relapse Months Ahead

Predicting relapse in multiple sclerosis (MS) remains difficult, limiting opportunities for timely intervention and monitoring. Although many people harbor latent Epstein-Barr virus (EBV), growing evidence... Read more

Microbiology

view channel
Image: Graphical Abstract (Jose A. Céspedes, Maria I. Montañez, Isabel M. Jiménez, et al. Magnetic nanoparticles enable clinically relevant in vitro diagnosis of beta-lactam allergy. Materials Today Bio (2026). DOI: 10.1016/j.mtbio.2026.103356)

Magnetic Nanoparticles Enable More Sensitive Beta-Lactam Allergy Testing

Penicillin allergy labels are common in clinical practice, yet many are incorrect and can lead to suboptimal antibiotic choices. Although 8%–25% of people report a penicillin allergy, only 1%–10% are truly... Read more

Pathology

view channel
Image Credit: Adobe Stock

Machine Learning Cytology Tool Improves Cancer Cell Identification

Cytological screening remains central to early cancer detection, but its accuracy depends heavily on expert interpretation of stained cells. Under conventional microscopy, malignant and reactive cells... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image: The acquisition adds Convergent Genomics’ UroAmp platform and proprietary urinary tumor DNA technology to Veracyte’s portfolio (Photo courtesy of Convergent Genomics)

Veracyte Acquisition Expands Urine-Based Bladder Cancer Monitoring Capabilities

Veracyte, Inc. has acquired Convergent Genomics, expanding its urology diagnostics offerings with the company’s UroAmp platform and proprietary urinary tumor DNA (utDNA) technology. UroAmp has been clinically... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.